These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 26491960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K, Morrone WR, O'Grady KE, Jones HE.
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine.
    O'Connor AB, Kelly BK, O'Brien LM.
    Drug Alcohol Depend; 2017 Nov 01; 180():200-203. PubMed ID: 28917206
    [Abstract] [Full Text] [Related]

  • 5. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE.
    Addiction; 2012 Nov 01; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [Abstract] [Full Text] [Related]

  • 6. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN, Murthy K, Bennett MM, Miller ES, Benjamin DK, Smith PB, Clark RH.
    J Perinatol; 2018 Jan 01; 38(1):75-79. PubMed ID: 29048415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of buprenorphine and methadone in the management of maternal opioid use disorder in full term pregnancies.
    Staszewski CL, Garretto D, Garry ET, Ly V, Davis JA, Herrera KM.
    J Perinat Med; 2020 Sep 25; 48(7):677-680. PubMed ID: 32681781
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone.
    Straub L, Bateman BT, Hernández-Díaz S, Zhu Y, Suarez EA, Vine SM, Jones HE, Connery HS, Davis JM, Gray KJ, Lester B, Terplan M, Zakoul H, Mogun H, Huybrechts KF.
    JAMA; 2024 Sep 10; 332(10):805-816. PubMed ID: 39133511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J, Heilig M, Sarman I.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):69-78. PubMed ID: 18355989
    [Abstract] [Full Text] [Related]

  • 16. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
    Kahila H, Saisto T, Kivitie-Kallio S, Haukkamaa M, Halmesmäki E.
    Acta Obstet Gynecol Scand; 2007 Jul 01; 86(2):185-90. PubMed ID: 17364281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, Shaw D, Saia K, Schiff DM.
    Drug Alcohol Depend; 2018 Nov 01; 192():45-50. PubMed ID: 30205307
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.